Drugmakers seek risk-averse management amid economic slump

The majority of pharmaceutical firms here are expected to become more conservative this year in the wake of the ongoing global credit crunch and economic downturn, strengthening risk management and mobilizing the workforce to full capacity to boost productivity and reduce costs.

Analysts said worsening global business conditions have aggravated the performance of domestic businesses over the...